NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india) arrow 11706.80 15.30 0.13%
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Rexahn Pharmaceuticals, Inc. (AMEX: RNN)

 
RNN Technical Analysis
2
As on 31st Oct 2017 RNN Share Price closed @ 1.76 and we RECOMMEND Buy for LONG-TERM with Stoploss of 1.56 & Strong Sell for SHORT-TERM with Stoploss of 2.26 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

RNN Share Price

Open 1.88 Change Price %
High 1.88 1 Day -0.11 -5.88
Low 1.70 1 Week 0.00 0.00
Close 1.76 1 Month -0.41 -18.89
Volume 1109806 1 Year 1.59 935.29
52 Week High 4.74 | 52 Week Low 0.13
 
AMEX USA Most Active Stocks
PAL 0.05 -50.00%
NGD 3.29 -6.80%
RBY 0.03 -70.00%
LODE 0.12 -7.69%
PBTH 8.23 0.37%
GGR 0.02 100.00%
VTG 0.05 -16.67%
SYRG 8.13 0.87%
GSX 0.02 0.00%
SHZ 0.10 -16.67%
 
AMEX USA Top Gainers Stocks
GGR 0.02 100.00%
ATC 0.37 60.87%
ATC 0.37 60.87%
ATC 0.37 60.87%
ATC 0.37 60.87%
MBA 0.20 25.00%
MBA 0.20 25.00%
MBA 0.20 25.00%
IG 7.68 22.49%
IG 7.68 22.49%
 
AMEX USA Top Losers Stocks
RBY 0.03 -70.00%
PAL 0.05 -50.00%
PAL 0.05 -50.00%
PAL 0.05 -50.00%
QBC 0.20 -33.33%
LBY 6.84 -25.33%
ATL 0.06 -25.00%
ATL 0.06 -25.00%
SNT 0.12 -20.00%
INV 0.14 -17.65%
 
 
RNN
Daily Charts
RNN
Intraday Charts
Whats New @
Bazaartrend
RNN
Free Analysis
 
RNN Important Levels Intraday
SUPPORT0.00
SUPPORT0.00
RESISTANCE1.93
RESISTANCE1.86
SUPPORT1.66
SUPPORT1.59
SUPPORT0.00
SUPPORT0.00
 
RNN Target for Month June
4th UP TARGET4.63
3rd UP TARGET3.71
2nd UP TARGET3.14
1st UP TARGET2.57
1st DOWN TARGET0.95
2nd DOWN TARGET0.38
3rd DOWN TARGET-0.19
4th DOWN TARGET-1.11
 
RNN Weekly Target
4th UP TARGET0.00
3rd UP TARGET0.00
2nd UP TARGET0.00
1st UP TARGET0.00
1st DOWN TARGET0.00
2nd DOWN TARGET0.00
3rd DOWN TARGET0.00
4th DOWN TARGET0.00
 
RNN Target for Year 2019
4th UP TARGET0
3rd UP TARGET0
2nd UP TARGET0
1st UP TARGET0
1st DOWN TARGET0
2nd DOWN TARGET0
3rd DOWN TARGET0
4th DOWN TARGET0
 
 
RNN Other Details
Segment EQ
Market Capital 39568448.00
Sector Healthcare
Industry Biotechnology
Offical website http://www.rexahn.com
 
RNN Address
RNN
15245 Shady Grove Road
Suite 455
Rockville, MD 20850
United States
Phone: 240-268-5300
Fax: 240-268-5310
 
RNN Latest News
 
Your Comments and Response on Rexahn Pharmaceuticals, Inc.
 
RNN Business Profile
Rexahn Pharmaceuticals, Inc., a development stage biopharmaceutical company, is engaged in the discovery, development, and commercialization of treatments for cancer and other medical needs. Its clinical stage oncology candidates comprise Archexin, an inhibitor of the protein kinase Akt, which has completed a Phase IIa clinical trials for the treatment of pancreatic cancer; RX-3117, a small molecule nucleoside compound with an anti-metabolite mechanism of action that is in Phase Ib clinical trials for the treatment of solid tumors; and RX-5902, a small molecule that inhibits the phosphorylation of p68 RNA helicase, which is in Phase I clinical trials for the treatment of solid tumors. The company’s pre-clinical product pipeline consists of RX-0047-Nano, a nanoliposomal anticancer HIF-1 alpha inhibitor; and RX-21101, an anticancer nano-polymer drug. It has various collaborative research and development relationships with universities, research institutions, and other organizations, including Teva Pharmaceutical Industries, Ltd.; Korea Research Institute of Chemical Technology; The University of Maryland Baltimore; Ohio State University; Revaax Pharmaceuticals LLC; and Rexgene Biotech Co., Ltd. The company is based in Rockville, Maryland.
 
© 2005-2019 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service